Pathological response to herceptin-containing neoadjuvant therapy in HER2 IHC2+/ISH+ and IHC3+ early-stage invasive ductal carcinoma
Author:
Tristan Jordan,Nay Nwe Nyein Chan,David L. Rimm,Haiying Zhan
Publication:
Human Pathology
© 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.